Akero Therapeutics
Why Robinhood?
You can watch AKRO and buy or sell other stocks, ETFs, and their options commission-free!About AKRO
Akero Therapeutics, Inc. is a clinical-stage company, which engages in the development of treatments for patients with serious metabolic diseases. The firm's lead product candidate, efruxifermin (EFX), is an analog of fibroblast growth factor 21, or FGF21, which is an endogenously expressed hormone that protects against cellular stress and regulates metabolism of lipids, carbohydrates, and proteins throughout the body.
AKRO Key Statistics
Stock Snapshot
The current Akero Therapeutics(AKRO) stock price is $54.65, with a market capitalization of 4.38B. The stock trades at a price-to-earnings (P/E) ratio of -14.58.
Akero Therapeutics(AKRO) stock opened on 2026-07-25 at —. The price climbed to — and dipped to —.
The Akero Therapeutics(AKRO)'s current trading volume is 0, compared to an average daily volume of 2M.
In the last year, Akero Therapeutics(AKRO) shares hit a 52-week high of $58.40 and a 52-week low of $21.34.
In the last year, Akero Therapeutics(AKRO) shares hit a 52-week high of $58.40 and a 52-week low of $21.34.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.